MLL3 Induced by Luteolin Causes Apoptosis in Tamoxifen-Resistant Breast Cancer Cells through H3K4 Monomethylation and Suppression of the PI3K/AKT/mTOR Pathway

The American Journal of Chinese Medicine
Han-Tsang WuDar-Ren Chen

Abstract

Tamoxifen is one of the most common hormone therapy drug for estrogen receptor (ER)-positive breast cancer. Tumor cells with drug resistance often cause recurrence and metastasis in cancer patients. Luteolin is a natural compound found from various types of vegetables and exhibit anticancer activity in different cancers. This study demonstrated that luteolin inhibits the proliferation and induces apoptosis of tamoxifen-resistant ER-positive breast cancer cells. Luteolin also causes cell cycle arrest at the G2/M phase and decreases mitochondrial membrane potential. Besides, luteolin reduces the levels of activated PI3K/AKT/mTOR signaling pathway. The combination treatment of luteolin and PI3K, AKT, or mTOR inhibitors synergistically increases apoptosis in tamoxifen-resistant ER-positive breast cancer cells. Ras gene family (K-Ras, H-Ras, and N-Ras), an activator of PI3K, was transcriptionally repressed by luteolin via induction of tumor suppressor mixed-lineage leukemia 3 (MLL3) expression. MLL3 increases the level of monomethylation of Histone 3 Lysine 4 on the enhancer and promoter region of Ras genes, thus causes repression of Ras expressions. Our finding implies that luteolin was a promising natural agent against tamoxifen r...Continue Reading

References

Feb 15, 2001·Cell Death and Differentiation·M H Harris, C B Thompson
Jan 8, 2003·Seminars in Oncology·Isaac CohenDebu Tripathy
Aug 13, 2005·Anti-cancer Drugs·Daniel Morgensztern, Howard L McLeod
May 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Suresh S RamalingamChandra P Belani
Jul 24, 2007·Trends in Molecular Medicine·Thomas EfferthBernd Kaina
Oct 24, 2007·Molecular and Cellular Biology·Shannon R PayneChristopher J Kemp
Jan 14, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Luis H CamachoAntoni Ribas
Feb 13, 2013·Nature Reviews. Clinical Oncology·Jordi RodonJosep Tabernero
Sep 26, 2013·Nature Reviews. Cancer·Caitriona HolohanPatrick G Johnston
May 29, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harold J BursteinJennifer J Griggs
Aug 13, 2014·World Journal of Clinical Oncology·Ozlem Yersal, Sabri Barutca
Sep 23, 2014·Pancreas·Jodee L JohnsonElvira Gonzalez de Mejia
May 23, 2015·Nature Reviews. Cancer·Rajesh C Rao, Yali Dou
Jun 11, 2016·Oncology Letters·Gloria M Calaf, Jorge Abarca-Quinones
Jul 18, 2017·Analytical Biochemistry·Ljubava D ZorovaDmitry B Zorov
Jan 23, 2019·EMBO Reports·Theodoros RampiasApostolos Klinakis
Jan 23, 2019·JAMA : the Journal of the American Medical Association·Adrienne G Waks, Eric P Winer
Feb 25, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Muhammad ImranMohammad S Mubarak

❮ Previous
Next ❯

Citations

May 5, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Olaf-Georg Issinger, Barbara Guerra

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis